A team of experts led by Northwestern Medicine have developed a standardized approach that will improve the measurement of esophageal function to better diagnose upper gastrointestinal disorders, detailed in a recent publication.
Microbiota transplantation is safe and effective for treating clostridioides difficile infections, according to a clinical trial published in the journal Gastroenterology.
Anti-inflammatory drugs alone are not sufficient to prevent pancreas inflammation following a common endoscopic procedure, according to a study recently published in The Lancet.
Northwestern Medicine scientists have developed an engineered probiotic capable of detecting inflammatory bowel disease, according to a study published in the Proceedings of the National Academy of Sciences.
Northwestern Medicine scientists have identified and characterized common symptoms and patterns in Eosinophilic esophagitis, according to a study published in the journal Gastroenterology, findings that will help predict how patients will respond to treatment.
Two new treatments for Crohn’s disease showed roughly equal performance in a clinical trial.
Josh Levitsky, MD, ’08 MS, has been selected as president-elect of the American Society of Transplantation (AST).
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.
A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.
Of the more than 20 episodes of the medical school’s Breakthroughs podcast produced in 2021, the most popular ranged across specialties from gastroenterology to nanotechnology. Listen to the top five episodes of the year and earn Continuing Medical Education credit.